Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

TRIMETHOBENZAMIDE HYDROCHLORIDE

TRIMETHOBENZAMIDE HYDROCHLORIDE

Standard Dose
300MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TRIMETHOBENZAMIDE HYDROCHLORIDE is listed in Drugs@FDA under application 205950 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TRIMETHOBENZAMIDE HYDROCHLORIDE Form and strength CAPSULE;ORAL - 300MG Sponsor HERITAGE PHARMA AVET Submission history Latest submission status date: 2023-11-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRIMETHOBENZAMIDE HYDROCHLORIDE is listed in Drugs@FDA under application 205950 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TRIMETHOBENZAMIDE HYDROCHLORIDE Form and strength CAPSULE;ORAL - 300MG Sponsor HERITAGE PHARMA AVET Submission history Latest submission status date: 2023-11-21 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
TRIMETHOBENZAMIDE HYDROCHLORIDE (TRIMETHOBENZAMIDE HYDROCHLORIDE) | Drug Monograph | MedicHelpline